Private · Company · Aksjeselskap
Amicoat AS
913 811 380 ↗Research and experimental development on natural sciences and engineering · NACE 72.100Askerwww.amicoat.com ↗
↳ Brreg · companies
MoneyNOK
Group revenue
kr 4.92M
Group net
kr -80.9M
Tenders won
0
Rolled up across the parent + 1 subsidiary — Peptide Patents AS alone is kr 779k.
rollup estimate · filed konsernregnskap not yet in Intelligo
Regnskapsregisteret · rollup across ownership edges (estimate)
Group financialsNOK
- Revenue
- Net profit
| FY24 | FY25 | |
|---|---|---|
| Revenue | 7.01M | 4.14M |
| Net profit | -17.2M | -80.8M |
Regnskapsregisteret · company_revenue
Key figuresBrønnøysund
FY24FY25TREND
Revenue7M4M
Operating result-17M-79M
Net result-17M-81M
Regnskapsregisteret · company_revenue
From the FY2025 accounts
FILEDAccounts filed for FY2025.
AUDITAudited by ERNST & YOUNG AS.
GROUPFiles as a parent with 1 subsidiaries.
BALANCEEquity kr 9.27M.
Regnskapsregisteret + Brreg roles · the annual-report PDF is a paid Brønnøysund document, so these are the filed facts, not extracted prose